▶ On Demand
Educational
✎ 0.5
GLP-1 Agonists: Semaglutide, Tirzepatide and the Cardiovascular Revolution
GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity. In this episode, Dr Anzal Qurbain explains how they work,…
On-demand clinical education for UK healthcare professionals — from guideline updates to therapeutic advances.
GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity. In this episode, Dr Anzal Qurbain explains how they work,…
JAK inhibitors have transformed inflammatory diseases from rheumatoid arthritis to eczema — but post-marketing safety data has reshaped how we use them.…
SGLT2 inhibitors started as diabetes drugs and became some of the most important medicines in cardiology and nephrology. Dr Anzal Qurbain covers…